$NVAX Recent News Novavax Inc. up 16% in premarket 6:52

New Post Public Reply Private Reply Replies (0) Message Board

Dec 24, 2013 at 12:43 PM

$NVAX Recent News

Novavax Inc. up 16% in premarket 6:52 a.m. Oct. 25, 2012 - Steve Gelsi
Novavax gains 11% on flu vaccine update 11:29 a.m. July 25, 2012 - Val Brickates Kennedy
Tuesday’s biggest gainers and decliners 6:42 p.m. March 1, 2011 - Kate Gibson
Novavax grabs drug-stock spotlight 12:49 p.m. March 1, 2011 - Val Brickates Kennedy
Novavax shares rally on government contract 10:03 a.m. March 1, 2011 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 3:38 p.m. July 27, 2010 - MarketWatch
Baxter, Affymetrix lead drug stocks lower 1:05 p.m. April 22, 2010 - Val Brickates Kennedy
Wednesday's biggest gaining and declining stocks 3:56 p.m. March 24, 2010 - MarketWatch
Poniard, Genzyme lead drug stocks south 10:10 a.m. March 24, 2010 - Val Brickates Kennedy
Drug stocks turn higher; Shire, XenoPort gain 12:59 p.m. Feb. 19, 2010 - Val Brickates Kennedy
Monday's biggest gaining and declining stocks 5:16 p.m. Feb. 8, 2010 - MarketWatch
Drug stocks turn higher; Cell Therapeutics tumbles 1:14 p.m. Feb. 8, 2010 - Val Brickates Kennedy
Novavax shares down 9% 9:37 a.m. Feb. 8, 2010 - Nick Godt
Novavax, Rovi end flu-vaccine-development plan 2:27 a.m. Feb. 8, 2010 - Robert Daniel
Novavax raises $21 million in stock offering 9:10 a.m. Dec. 9, 2009 - Val Brickates Kennedy
Dyax, Santarus, CytRx soar; Hemispherx craters 11:38 a.m. Dec. 2, 2009 - Val Brickates Kennedy
Drug stocks split; Theravance slides on setback 1:22 p.m. Nov. 30, 2009 - Val Brickates Kennedy
Novavax sees Phase III vaccine testing in 2010 9:32 a.m. Nov. 30, 2009 - Val Brickates Kennedy
Inovio, Merck gain; Novavax falls 4:26 p.m. Nov. 20, 2009 - Val Brickates Kennedy
Friday's biggest gaining and declining stocks 4:25 p.m. Nov. 20, 2009 - MarketWatch

Piper Jaffray Top Stocks to Buy for 2014 7:44 a.m. Dec. 18, 2013 - 247WallSt.com
Perilous Reversal Watch: Novavax (NVAX) 9:50 a.m. Dec. 17, 2013 - TheStreet.com
Mid-Afternoon Market Update: Markets Rise as Twitter Pulls Back 3:07 p.m. Dec. 16, 2013 - benzinga.com
Novavax Share Price Reaches New All-Time High 2:18 p.m. Dec. 16, 2013 - benzinga.com
Novavax jumps, Wedbush sees big upside 11:41 a.m. Dec. 16, 2013 - Seeking Alpha
Five Big Analyst Stock Picks for 2014 7:17 a.m. Dec. 14, 2013 - 247WallSt.com
Can Novavax, Inc. (NVAX) Continue to Rise? - Tale of the Tape 6:24 a.m. Dec. 12, 2013 - Zacks.com
Sell Organovo, Buy Novavax 3:09 a.m. Dec. 11, 2013 - Seeking Alpha
Novavax's CEO Presents at Piper Jaffray HC 2013 Conference (Transcript) 5:30 p.m. Dec. 3, 2013 - Seeking Alpha
New Top Stocks to Buy Under $10 with Big Upside 7:16 a.m. Nov. 18, 2013 - 247WallSt.com
Breakthrough In Virus Vaccination Can Instigate A Super Run Of Novavax 12:41 p.m. Nov. 17, 2013 - Seeking Alpha
Benzinga's Top #PreMarket Gainers 7:11 a.m. Nov. 14, 2013 - benzinga.com
Novavax Shares Edge Higher as the New England Journal of Medicine Has Published Data on Co.'s Bird Flu Vaccine 4:26 p.m. Nov. 13, 2013 - benzinga.com
Novavax Management Discusses Q3 2013 Results - Earnings Call Transcript 7:20 p.m. Nov. 7, 2013 - Seeking Alpha
Two Speculative Biotech Stocks 11:00 a.m. Oct. 31, 2013 - RealMoney.com
Buy Novavax On Vaccine Market Growth 2:31 p.m. Oct. 30, 2013 - Seeking Alpha
First Week Of NVAX December 21st Options Trading 10:54 a.m. Oct. 23, 2013 - TheStreet.com
Wall Street Analysts’ Top Stocks to Buy Trading Under $10 7:35 a.m. Sept. 30, 2013 - 247WallSt.com
John McCamant Scans Under The Radar For Promising Biotechs 9:11 a.m. Sept. 27, 2013 - Seeking Alpha
NVAX: Insiders Vs. Shorts 2:48 p.m. Sept. 26, 2013 - TheStreet.com

Announcements, Studies, and Corporate Updates by Healthcare Companies - Research Report on Horizon Pharma, Novavax, WuXi PharmaTech, Chelsea Therapeutics, and Anika Therapeutics 8:00 a.m. Today - PR Newswire
Technical Research on Equities: Ariad Pharma, MannKind, Galena Biopharma, and Novavax 8:00 a.m. Dec. 23, 2013 - PR Newswire
Pre-Market Breakdown: Galena Biopharma Inc., Novavax Inc., Ariad Pharma Inc., and MannKind Corp. 8:00 a.m. Nov. 27, 2013 - PR Newswire
Companies Report Corporate Growth and Positive Clinical Data - Research Report on Humana, Molina Healthcare, Novavax, Kindred Healthcare, and Repligen 8:00 a.m. Nov. 27, 2013 - PR Newswire
Novavax to Present at the 25th Annual Piper Jaffray Healthcare Conference 4:05 p.m. Nov. 26, 2013 - GlobeNewswire
Financial Reports, Partnerships, Settlement Agreements, and Strategic Acquisitions - Research Report on Mallinckrodt, WellCare, Mindray, Oxygen Biotherapeutics, and Novavax 8:00 a.m. Nov. 19, 2013 - PR Newswire
New England Journal of Medicine Publishes Positive Data From Clinical Trial of Novavax' Vaccine Against H7N9 Avian Flu 5:01 p.m. Nov. 13, 2013 - GlobeNewswire
Novavax Reports Third-Quarter 2013 Financial Results 4:10 p.m. Nov. 7, 2013 - GlobeNewswire
ACAD, CRTX, MACK and NVAX added to NASDAQ Healthcare Stock Watch List at EPR 9:29 a.m. Nov. 7, 2013 - ACCESSWIRE
Clinical Trials Results, Financial Results, and Upcoming Earnings Releases- Research Report on Teleflex, Oxygen Biotherapeutics, Novavax, Prana Biotechnology and Hanger Orthopedic 8:00 a.m. Nov. 4, 2013 - PR Newswire
Morning Research: Ariad Pharma Inc., MannKind Corp., Novavax Inc., and Galena Biopharma Inc. 12:30 p.m. Nov. 1, 2013 - PR Newswire
Novavax to Report Third Quarter 2013 Financial Results on November 7, 2013 3:58 p.m. Oct. 30, 2013 - GlobeNewswire
Pre-Market Review: MannKind Corp., Galena Biopharma Inc., Ariad Pharmaceuticals Inc., and Novavax Inc. 2:40 p.m. Oct. 10, 2013 - PR Newswire
Product Development Strategies, FDA Approval, Incremental Agreement, New Clinical Studies, and Other Announcements - Research Report on Amarin, Discovery Labs, Auxilium, Novavax, and Accuray 7:00 a.m. Oct. 9, 2013 - PR Newswire
Novavax Initiates Dose-Confirmatory Phase 2 Clinical Trial of its RSV Vaccine Candidate 3:36 p.m. Oct. 7, 2013 - GlobeNewswire
Novavax Completes $100 Million Public Offering of Common Stock 10:29 a.m. Sept. 27, 2013 - GlobeNewswire
Beginning New Clinical Trials, Innovation Recognitions, Expansion in Patent Portfolios, Product Distributions and Offerings - Research Report on Allscripts, Novavax, Amarin, Acura, and Catalyst 7:00 a.m. Sept. 27, 2013 - PR Newswire
Novavax Prices Public Offering of Common Stock 7:07 a.m. Sept. 24, 2013 - GlobeNewswire
Novavax to Initiate Seasonal and Pandemic Influenza Trials in Collaboration With BARDA 7:00 a.m. Sept. 24, 2013 - GlobeNewswire
Novavax to Host an Analyst and Investor Update Call With Webcast 5:25 p.m. Sept. 17, 2013 - GlobeNewswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Novo's CagriSema Trial Shows Promising Obesity Results

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Novo's CagriSema Trials Show Promising Weight Loss

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

KINGRVER Boosts RV Comfort with New Water Heater Lineup

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Breakthrough T1D Pushes Global T1D Awareness Forward

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

JOYEE N01 Debuts Globally with First 2,000 Deliveries

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Uber Data Breach: Class Action Investigation Begins

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Webull Faces Class Action: Key Details for Investors

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...